Latest SBTX reports update at 2024-05-09: 2024-Q12023-Q42023-Q1
Silverback Therapeutics logo
Silverback Therapeutics SBTX
$ 6.1 4.99%

Silverback Therapeutics EV/EBITDA Ratio 2011-2024 | SBTX

Annual EV/EBITDA Ratio Silverback Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.07 -1.06 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.07 -1.06 0.00148